{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:09Z","timestamp":1789020429713,"version":"build-2803163510"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Donor cell leukemia is a rare but severe complication following an allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in patients with non-malignant diseases, due to its aggressive clinical progression and poor prognosis. In recent years, with the increasing number of umbilical cord blood stem cell transplantation cases, umbilical cord blood\u2013derived donor cell leukemia has garnered growing attention. Although umbilical cord blood cells may inherently carry tumor precursor characteristics, host environmental factors, immunosuppression, and chemotherapy during transplantation can exacerbate their transformation into leukemia. Herein, we report a clinical case of a pediatric patient with severe aplastic anemia who developed umbilical cord blood\u2013derived early T-cell precursor acute lymphoblastic leukemia 2\u2005years and 5\u2005months after receiving an allo-HSCT. Despite multiple chemotherapy regimens, the patient ultimately failed to achieve remission and succumbed to the disease. Although this outcome is regrettable and highlights the refractory nature of post-transplant donor cell leukemia, further investigation into its molecular biological mechanisms is warranted to develop early prevention strategies and more effective therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fped.2026.1932013","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:30:53Z","timestamp":1789018253000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Donor-derived early T-cell precursor acute lymphoblastic leukemia following an allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/life12040559","article-title":"Lessons learned from donor cell-derived myeloid neoplasms: report of three cases and review of the literature","volume":"12","author":"Deshmukh","year":"2022","journal-title":"Life"},{"key":"B2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1159\/000170252","article-title":"Development of leukemia in donor cells after allogeneic stem cell transplantation: a survey of the European group for blood and marrow transplantation (EBMT)","volume":"90","author":"Hertenstein","year":"2005","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(71)90998-6","article-title":"Leukaemic transformation of engrafted human marrow cells in vivo","volume":"1","author":"Fialkow","year":"1971","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1182\/blood-2005-06-2551","article-title":"First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation","volume":"106","author":"Fraser","year":"2005","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"750789","DOI":"10.3389\/fonc.2021.750789","article-title":"Early T-cell precursor acute lymphoblastic leukemia: diagnosis, updates in molecular pathogenesis, management, and novel therapies","volume":"11","author":"Sin","year":"2021","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/bjh.15960","article-title":"Early T precursor acute lymphoblastic leukaemia\/lymphoma shows differential immunophenotypic characteristics, including frequent CD33 expression and an in vitro response to targeted CD33 therapy","volume":"186","author":"Khogeer","year":"2019","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41409-021-01214-z","article-title":"Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome","volume":"56","author":"Williams","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12885-020-6709-7","article-title":"Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2015.06.010","article-title":"Targeting the inactive conformation of JAK2 in hematological malignancies","volume":"28","author":"Silvennoinen","year":"2015","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1182\/blood-2005-09-3781","article-title":"Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation","volume":"107","author":"Mielcarek","year":"2006","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bmt.1705312","article-title":"Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient","volume":"37","author":"Shimada","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-4608(91)90135-H","article-title":"Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute nonlymphocytic and acute lymphoblastic leukemias","volume":"51","author":"Palka","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0145-2126(82)90067-4","article-title":"The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation","volume":"6","author":"Boyd","year":"1982","journal-title":"Leuk Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick","year":"2014","journal-title":"Br J Haematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S2352-3026(15)00254-9","article-title":"Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis","volume":"3","author":"Conter","year":"2016","journal-title":"Lancet Haematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.10286","article-title":"Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin","volume":"72","author":"Komeno","year":"2003","journal-title":"Am J Hematol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1932013\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:30:56Z","timestamp":1789018256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1932013\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":19,"alternative-id":["10.3389\/fped.2026.1932013"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1932013","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1932013"}}